Products: Fanhdi Alphanate (Factor VIII and von Willebrand Factor)
Tasks: Scientific expert of the coagulation portfolio, business support for EU and ROW countries
Medical plan strategy in collaboration with Marketing and Market access departments
Scientific update for internal customers -sales teams, marketing-, external customers: on-line continuing medical education, scientific symposia for both local and international scientific societies, train the trainer's sessions (von Willebrand disease)
Collaboration with the Clinical Research department (follow up of the investigational clinical trials, ongoing trials and to initiate)
Design and implementation of post-authorization studies in von Willebrand Disease, Hemophilia A and ITI
Support to Marketing Department in generation of promotional materials: review of claims and all statements of the scientific content following the standards of compliance in Pharmaceutical Industry
Collaboration with the Business Development department for exploring new business proposals in hematology.
Hypertension: Dafiro HCT , valsartan family (valsartan, amlodipine and hydrochlorothiazide)
Oral direct anticoagulants: launch of dabigatran (Pradaxa , co-promotion with Boehringer-Ingelheim)
Tasks: Being the scientific reference on the cardiovascular therapeutic area for both internal and external stakeholders and customers
Implementation of the Tactical Medical Plan following the Strategic Brand Plan of the therapeutic area products: KOL engagement plan, visory boards) medical training -sales representatives and MSL- medical training of the external costumer –primary care, specialists-, close collaboration with Market Access (delphi studies, pharmacoeconomic study), post-authorization studies design and follow up.)
Review of promotional materials.
Medical Advisor
MENARINI Laboratories
01.2010 - 01.2014
Sexual Medicine Area
From 2012 to 2014
Launch of a drug for premature ejaculation (Priligy or dapoxetine) April, 2013
Launch of a drug for erectile dysfunction (Spedra or avanafil), May 2014
Tasks: active search of new KOL (new business unit)
Leading Advisory Boards to determine the strategic medical plan pre and post-lunch of each portfolio product (studies, medical activities
Becoming the scientific reference for the follow-up of the strategic medical plan and development of new scientific proposals (protocols of clinical or epidemiological studies, training courses, etc.)
Medical Advisor
SOLVAY PHARMA (now AbbVie since 2010)
01.2006 - 01.2010
Central Nervous System
Duodopa (levodopa and carbidopa intraduodenal administration)
Drug for hospital use
Indicated for the treatment of advanced Parkinson's disease
Main task, preparation of scientific documentation for its approval in hospital pharmacy services and presentations in neurology services
Mature Products
Urology: Pronitol or Pygium Africanum (symptomatic treatment of benign prostatic hyperplasia)
Tasks: Medical Marketing activities: preparation of promotional materials, scientific training medical representatives
Clinical research activities: following of the multicenter phase III studies at the local level (parkinson's disease, schizofrenia: antipsychotics, etc), of post-authorization studies (Parkinson's disease), quality of life studies (intestinal constipation).
Drug Safety Manager and Responsible of Good Clinical Practices (GCP)
SALVAT, S.A. Laboratories
01.2005 - 01.2006
All the tasks involved in Pharmacovigilance
Quality assurance of GCP in clinical trials (phase I, II and III).
Tasks: Preparation of scientific documentation: scientific literature searches, updates of monographies
Review of promotional materials
Scientific training of medical representatives (primary care and specialists).
Specialization, training in Clinical Pharmacology
Hospital de la Santa Creu i Sant Pau
Barcelona
01.2001 - 01.2004
Phase I Clinical Trials: bioequivalence studies to obtain the registry of generic pharmaceutical specialties from national and multinational laboratories
Assistance to the monthly meetings of the Clinical Research Ethics Committee of the hospital
Collaborator as Medical Writer for Prous Science Editorial
Functions: medical writing of briefings of clinical trials for including in a database.
Medical Affairs Manager
CSL Behring
01.2023
Medical Affairs Manager of Hematology and Thrombosis
Spain and Portugal
Coagulation portfolio and investigational products: hematology and cardiovascular area
Hemophilia A, B, von Willebrand and Critical Bleeding
Products: Pre-launch of gene therapy, Hemgenix, Afstyla, Idelvion, Haemate P, Riastap and the corresponding brands in Portugal
Tasks: Scientific expert reference for Gene therapy in hemophilia B, Hemgenix
Responsible for the Coagulation portfolio strategic and tactical medical plan: generation and review of the Tactical Medical Plan in collaboration with Marketing and Market access departments
Advisory Boards for gene therapy, von Willebrand disease
Continuous medical education: external (HCP), organization of scientific symposia, train the trainers
Support to Regulatory Affairs, Pharmacovigilance and Medical Information
Medical Affairs Manager of the hematology Team
Team management of 3 Regional Medical Engagement Specialists reporters, new role of MSLs (4 in the coming months).
Education
Degree in Medicine and Surgery -
University of Barcelona
01.2001
Postgraduate "Medicine of the Pharmaceutical Industry" -
Autonomous University of Barcelona
Skills
Windows environment and Microsoft Office
Clinical Leadership
Patient care management
Risk Management
Decision-Making
Critical Thinking
Budget Development
Interdepartmental Functions Coordination
Employee Training Program
Team building
Continuous Improvement
Time Management
Congresses
ISTH congress 2019 to 2021
EAHAD congress 2019 -2024
EHA congress 2019 to 2021
SEHH and SETH Spanish congress, 2019 to 2023
European Society of Cardiology 2015 London and 2017 Barcelona
National Congresses Spanish Society of Cardiology (SEC, Clinical Cardiology Section)
European Society of Atherosclerosis 2015, Glasgow
National congresses of national atherosclerosis 2015 La Rioja, 2016 Granada and 2017 Cádiz
European congresses of the European Urology Association Stockholm 2014 and Milan, 2013
International Sexual Society of Medicine, Amsterdam 2012 and Istanbul 2014
National urology congresses of the Spanish Association of Urology, in Granada, 2013 and in Tenerife, 2014
Congresses and courses of the Puigvert Foundation
Spanish Association of Ambulatory Surgery, Oviedo 2011
The European Society of Regional Anesthesia, ESRA-Spain, Barcelona 2011
Spanish Pain Society Congress, May 2010
Movement Disorders Society Congress, Istanbul, June 2007
Spanish Society of Neurology, November 2006
United European Gastro Week, Stockholm, October 2011
International Headache Society, Berlin, June 2011
Spanish Society of Rheumatology Congress, May 2010
National Medicine Congresses of Primary Care: SEMERGEN Society, from 2015 to 2017, SEMG Society from 2015 to 2017
AMIFE Congress. Association of Medicine of the Pharmaceutical Industry, November 2009 and 2014
Pharmacogenetics Conference. Hospital of Sant Pau. 5 hours, January 2003
XVIII National Congress of the Spanish Society of Clinical Pharmacology, October 17-19, 2002, Navarra
Conference "Medical Doctors, Clinical Research and Pharmaceutical Industry" at Official College of Medical Doctors of Barcelona (C.O.M.B.) November 30, 2001
XVII National Congress of the Spanish Society of Clinical Pharmacology, from November 22 to 24, 2001, Sevilla
Complementary Education
Seminars for doctoral thesis, Department of Pharmacology, Therapeutics and Toxicology, Autonomous University of Barcelona, 2001-2002
Training in the Clinical Pharmacology Department, Hospital de la Santa Creu i Sant Pau, 2001-2004
Training in Pharmacovigilance, Various institutions, 2005
Languages
Fluent, Fluent, Advanced
Languages
Spanish
First Language
English
Advanced (C1)
C1
Catalan
Proficient (C2)
C2
Timeline
Medical Affairs Manager
CSL Behring
01.2023
Medical Manager
Grifols S.A. Laboratories
04.2019 - 12.2022
Medical Manager
ESTEVE Laboratories
03.2015 - 12.2018
Medical Advisor
MENARINI Laboratories
01.2010 - 01.2014
Medical Advisor
SOLVAY PHARMA (now AbbVie since 2010)
01.2006 - 01.2010
Drug Safety Manager and Responsible of Good Clinical Practices (GCP)
SALVAT, S.A. Laboratories
01.2005 - 01.2006
Medical Advisor
NOVARTIS
01.2004 - 01.2005
Specialization, training in Clinical Pharmacology
Hospital de la Santa Creu i Sant Pau
01.2001 - 01.2004
Degree in Medicine and Surgery -
University of Barcelona
Postgraduate "Medicine of the Pharmaceutical Industry" -
Jefa de Sección de Acondicinamiento / Facilitadora at Instituto Grifols, S.A.Jefa de Sección de Acondicinamiento / Facilitadora at Instituto Grifols, S.A.